Forte Biosciences, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE15-12GForte Biosciences, Inc.FBRXSep 8

   Deregistration notice

2. ROUTINE15-12GForte Biosciences, Inc.FBRXSep 8

   Deregistration notice

3. ROUTINE15-12GForte Biosciences, Inc.FBRXSep 8

   Deregistration notice

4. ROUTINESCHEDULE 13G/AForte Biosciences, Inc.FBRXSep 8

   Ownership stake disclosure by FEDERATED HERMES, INC. (amended)

   FEDERATED HERMES, INC., filed by

5. ROUTINEEFFECTForte Biosciences, Inc.FBRXSep 2

   Registration declared effective

6. ROUTINEEFFECTForte Biosciences, Inc.FBRXSep 2

   Registration declared effective

7. ROUTINEEFFECTForte Biosciences, Inc.FBRXSep 2

   Registration declared effective

8. ROUTINEEFFECTForte Biosciences, Inc.FBRXSep 2

   Registration declared effective

9. ROUTINEEFFECTForte Biosciences, Inc.FBRXSep 2

   Registration declared effective

10. ROUTINEEFFECTForte Biosciences, Inc.FBRXSep 2

    Registration declared effective

11. ROUTINEPOS AMForte Biosciences, Inc.FBRXAug 27

    POS AM filing

12. ROUTINEPOS AMForte Biosciences, Inc.FBRXAug 27

    POS AM filing

13. ROUTINEPOS AMForte Biosciences, Inc.FBRXAug 27

    POS AM filing

14. ROUTINEPOS AMForte Biosciences, Inc.FBRXAug 27

    POS AM filing

15. ROUTINEPOS AMForte Biosciences, Inc.FBRXAug 27

    POS AM filing

16. ROUTINEPOS AMForte Biosciences, Inc.FBRXAug 27

    POS AM filing

17. ROUTINE4Forte Biosciences, Inc.FBRXAug 27

    9 insider filings

    Steven Kornfeld, insider filing for FBRX

    Show all 9

    • 4Insider filing for FBRXAug 27
    • 4Insider filing for FBRXAug 27
    • 4Insider filing for FBRXAug 27
    • 4Insider filing for FBRXAug 27
    • 4Insider filing for FBRXAug 27
    • 4Insider filing for FBRXAug 27
    • 4Insider filing for FBRXAug 27
    • 4Insider filing for FBRXAug 27
    • 4Insider filing for FBRXAug 27

    Steven Kornfeld, reporting

18. ROUTINES-8 POSForte Biosciences, Inc.FBRXAug 27

    S-8 POS filing

19. ROUTINES-8 POSForte Biosciences, Inc.FBRXAug 27

    S-8 POS filing

20. ROUTINES-8 POSForte Biosciences, Inc.FBRXAug 27

    S-8 POS filing

21. ROUTINES-8 POSForte Biosciences, Inc.FBRXAug 27

    S-8 POS filing

22. ROUTINES-8 POSForte Biosciences, Inc.FBRXAug 27

    S-8 POS filing

23. ROUTINES-8 POSForte Biosciences, Inc.FBRXAug 27

    S-8 POS filing

24. ROUTINES-8 POSForte Biosciences, Inc.FBRXAug 27

    S-8 POS filing

25. ROUTINES-8 POSForte Biosciences, Inc.FBRXAug 27

    S-8 POS filing

26. ROUTINES-8 POSForte Biosciences, Inc.FBRXAug 27

    S-8 POS filing

27. ROUTINES-8 POSForte Biosciences, Inc.FBRXAug 27

    S-8 POS filing

28. ROUTINES-8 POSForte Biosciences, Inc.FBRXAug 27

    S-8 POS filing

29. ROUTINES-8 POSForte Biosciences, Inc.FBRXAug 27

    S-8 POS filing

30. ROUTINE8-KForte Biosciences, Inc.FBRXAug 27

    Current report

31. ROUTINESC TO-T/AForte Biosciences, Inc.FBRXAug 27

    Tender offer (amended)

    Se Argenx, filed by

32. ROUTINESC 14D9/AForte Biosciences, Inc.FBRXAug 27

    Tender offer response (amended)

33. NOTABLE25-NSEForte Biosciences, Inc.FBRXAug 27

    Delisting notice

    Nasdaq Stock Market LLC, filed by

34. ROUTINESC 14D9/AForte Biosciences, Inc.FBRXAug 21

    Tender offer response (amended)

35. ROUTINESC TO-T/AForte Biosciences, Inc.FBRXAug 20

    Tender offer (amended)

    Se Argenx, filed by

36. ROUTINESC 14D9/AForte Biosciences, Inc.FBRXAug 19

    Tender offer response (amended)

37. ROUTINESCHEDULE 13G/AForte Biosciences, Inc.FBRXAug 14

    Ownership stake disclosure by ORBIMED ADVISORS LLC (amended)

    ORBIMED ADVISORS LLC, filed by

38. ROUTINESCHEDULE 13G/AForte Biosciences, Inc.FBRXAug 13

    Ownership stake disclosure by Affinity Asset Advisors, LLC (amended)

    Affinity Asset Advisors, LLC, filed by

39. ROUTINESCHEDULE 13G/AForte Biosciences, Inc.FBRXAug 13

    Ownership stake disclosure by Janus Henderson Group Ltd. (amended)

    Janus Henderson Group Ltd., filed by

40. NOTABLE10-QForte Biosciences, Inc.FBRXAug 12

    Quarterly report

41. ROUTINESCHEDULE 13G/AForte Biosciences, Inc.FBRXAug 12

    Ownership stake disclosure by Adage Capital Management, L.P. (amended)

    Adage Capital Management, L.P., filed by

42. ROUTINESCHEDULE 13GForte Biosciences, Inc.FBRXAug 11

    Ownership stake disclosure by GLAZER CAPITAL, LLC

    GLAZER CAPITAL, LLC, filed by

Older filings on EDGAR